In 2017, The University of Hong Kong (HKU) celebrated "130 Years of Medicine in Hong Kong", a journey that began in 1887 with the establishment of the Hong Kong College of Medicine for Chinese, later renamed the Hong Kong College of Medicine in 1907. When HKU was founded in 1911, the College was amalgamated into the Faculty of Medicine.

The Faculty has evolved into HKU's largest medical faculty, with over 400 full-time academic and academic-related staff, and 800 research and research-related support personnel. The undergraduate student population stands at 2,900 and postgraduate students number 1,500. The key to this growth is Queen Mary Hospital (QMH), which is the flagship teaching hospital for the Medical Faculty.

Professor Ivan Hung Fan-Ngai is a Clinical Professor at the Department of Medicine and Assistant Dean (Clinical Curriculum & Assessment) at the LKS Faculty of Medicine at HKU. He is also an Honorary Consultant at QMH, and a dual specialist in Infectious Diseases and Gastroenterology & Hepatology.

After joining the Faculty's Deanery in 2016, Professor Hung revamped the MBBS Integrated Block into the Clinical Foundation Block that prepares students for clinical training after their Enrichment Year. He also rejuvenated the Faculty's Problem-Based Learning Curriculum, of which he is also Chairman.

He is a supervisor and an examiner for both MD and PhD students of the Faculty. He is a certified Practical Assessment of Clinical Examination Skills (PACES) examiner for the UK's Royal Colleges of Physicians, and trainer and examiner for two Specialty Boards, in Infectious Diseases and Gastroenterology & Hepatology, of the Hong Kong College of Physicians. Recently, Professor Hung became a member of the China Consortium of Elite Teaching Hospitals for Residency Education and the Education Committee of the Hong Kong Academy of Medicine, and has represented the Faculty at both. He is a member of the Education & Accreditation Committee and the Licentiate Examination Sub-committee of the Hong Kong Medical Council.

His research areas include vaccinology against influenza and hepatitis B, innovative treatment of severe influenza and the prevention of pneumococcal infections, and the treatment of resistant Helicobacter pylori infection. He and his team have pioneered the use of topical imiquimod before intradermal influenza and hepatitis B vaccination, and were the first to prove convalescent plasma and H-IVIG reduced mortality in patients with severe influenza in prospective clinical trials.

Professor Hung obtained his medical degree from the University of Bristol in 1996 and worked at the University of Cambridge Medical School and London's Charing Cross Hospital before joining the Department of Medicine at QMH in 1999. He switched to academia at HKU as Clinical Assistant Professor in 2008. In 2011, he obtained his MD degree and was awarded the Sir Patrick Manson Gold Medal award for the best MD thesis. He was also awarded the Richard Yu Lectureship and Medal from the Hong Kong College of Physicians, and the Research Output Prize from HKU in 2016.

He was a Visiting Fellow in Infectious Diseases at Tufts-New England Medical Center, Boston, and is currently a Fellow of the Royal Colleges of Physicians of London and Edinburgh.

Professor Hung is the Board and Founding Member of the World Association for Infectious Diseases and Immunological Disorders, and a member of eight international advisory boards for vaccines and infectious diseases. He is a referee for the National Medical Research Council, Singapore and a member of the HMRF Grant Review Board, Food & Health Bureau, Hong Kong SAR. He has published more than 170 international peer-reviewed original articles and is a regular reviewer of top journals, including The Lancet and Annals of Internal Medicine, and is on the editorial boards of other journals. He was ranked in HKU's top 1% scientists in 2013, with a current H-Index of 37.